Company Update1 Min Read InvestyWise NewsonSeptember 19, 2025 CESC: Green Power Arm to Establish 3+ GW Solar Cell Plant CESC’s wholly-owned subsidiary, CESC Green Power Ltd, is set to establish a 3+ GW solar cell/module plant along with battery…
Insider Trading / SAST1 Min Read InvestyWise NewsonSeptember 19, 2025 SMBC Group: Increases Stake in YES Bank to 20% SMBC Group has increased its stake in YES Bank to 20% through an off-market transaction. The acquisition involves 6,271,235,194 shares,…
Insider Trading / SAST2 Min Read InvestyWise NewsonSeptember 19, 2025 Dr. Reddy’s: Promoter Share Transfers for Succession Planning Dr. Reddy’s Laboratories has announced the transfer of 17,17,26,540 equity shares, representing 20.58% of the company, from promoters to…
Company Update1 Min Read InvestyWise NewsonSeptember 19, 2025 BLS International: Outcome of Annual General Meeting Held on September 16, 2025 BLS International has announced the key outcomes of its Annual General Meeting (AGM) held on September 16, 2025. The shareholders approved the…
Insider Trading / SAST1 Min Read InvestyWise NewsonSeptember 19, 2025 Dr. Reddy’s: Promoter Share Transfers to Family Trusts Dr. Reddy’s Laboratories has announced the transfer of promoter shares totaling 17,17,26,540 equity shares, or 20.58%, to VSD Family…
Insider Trading / SAST1 Min Read InvestyWise NewsonSeptember 19, 2025 Natco Pharma: Promoter Group Member Disposes of Shares in Open Market A member of Natco Pharma’s promoter group, Satya Vani Nannapaneni, has sold 23,000 equity shares in the open market. This transaction…
Insider Trading / SAST1 Min Read InvestyWise NewsonSeptember 19, 2025 State Bank of India: Sells 13.18% Stake in YES Bank to Sumitomo Mitsui Banking Corporation State Bank of India (SBI) has divested a 13.18% stake in YES Bank Limited, equivalent to 413,44,04,897 equity shares. This sale was executed…
Company Update2 Min Read InvestyWise NewsonSeptember 19, 2025 Glenmark: Outlook Revised to Positive Following AbbVie Licensing Deal Glenmark Pharmaceuticals’ outlook has been revised to Positive by Crisil Ratings, following its exclusive licensing deal with AbbVie for…
Company Update1 Min Read InvestyWise NewsonSeptember 19, 2025 Aurobindo Pharma: CuraTeQ Announces Positive Phase 3 Results for Denosumab Biosimilar CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, announced the successful completion of a Phase 3 clinical study for its denosumab…
Insider Trading / SAST1 Min Read InvestyWise NewsonSeptember 19, 2025 Cohance Lifesciences: Jusmiral Holdings Reduces Stake Via Open Market Sale Jusmiral Holdings Limited has reduced its stake in Cohance Lifesciences through an open market sale of 34,148,000 shares on September 18,…